Olivia has developed expertise across a range of therapeutics areas over the course of 7+ years of experience in life sciences research and consulting, but she has a specific interest in rare diseases, immunology, and ophthalmology. In particular, she has a passion for supporting clients with highly innovative technology platforms in the development and commercialization of their therapies for patients with significant unmet need. During her time at ClearView, Olivia has assisted a wide array of clients, ranging from leading biopharmaceutical companies to early-stage biotechs, in addressing their highest-priority strategic issues. Through this diversity of experience, Olivia has a demonstrated track record of ensuring commercial, clinical, and scientific factors are effectively considered to address her clients’ strategic questions.
While her historical experience spans a broad range of project types, Olivia focuses on commercialization strategy, including new product planning, portfolio prioritization, M&A and due diligence support, and strategic launch planning. Olivia received her B.A. in Economics and a Secondary Field in Chemistry from Harvard University.
Debbi Amanti Belanger